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Objective: To evaluate the immunohistochemical expression of MMP-1, -2, -7, -9 and -26 in
oral squamous cell carcinomas (SCCs) according to tumour site and histological grade of
malignancy.
Study design: Fifteen cases of SCC of the lower lip and 15 cases of tongue SCC were selected
and divided into low grade malignancy (n = 17) and high grade malignancy (n = 13).
Results: Higher immunohistochemical expression of MMPs by neoplastic cells was observed
in tongue SCCs, with a statistically significant difference for MMP-9 (P < 0.05). High-grade
SCCs showed a higher expression of MMPs, except for MMP-2, with a statistically significant
difference for MMP-7 (P < 0.05) and MMP-26 (P < 0.05). In addition, a direct association was
observed between morphological scores of malignancy and MMP immunoreactivity, with
the association being significant for MMP-7 and MMP-26.
Conclusion: The present results demonstrate the important role of MMPs in the development
of SCCs of the lower lip and tongue.
# 2011 Elsevier Ltd. All rights reserved.
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Squamous cells carcinomas (SCCs) account for approximately
95% of all oral malignant neoplasms and for about 38% of all
malignant head and neck tumours,1 affecting especially the
tongue and lip.2,3 The aggressiveness of these tumours
depends on a series of factors; however, tongue carcinomas
generally exhibit a much more aggressive biological and
clinical behaviour, whereas lip tumours tend to have a good
prognosis and low metastatic potential.4* Corresponding author at: Universidade Federal do Rio Grande do Nor
Lagoa Nova, CEP 59056-000, Natal, RN, Brazil. Tel.: +55 84 3215 4138; f
E-mail address: roseanafreitas@hotmail.com (R.d.A. Freitas).
0003–9969/$ – see front matter # 2011 Elsevier Ltd. All rights reserve
doi:10.1016/j.archoralbio.2010.11.022The prognosis of SCC is related to the proliferative activity
of the tumour, degree of differentiation, and invasion and
metastatic potential.5,6 The last two processes involve multi-
ple steps, such as degradation of the basement membrane and
extracellular matrix (ECM), alterations in cell adhesiveness,
tumour cell motility, and angiogenesis.7
At present, therapeutic decisions in SCCs are based on
clinical and pathological parameters, including age, metasta-
sis stage and histological grade of the tumour. However, these
factors frequently fail to distinguish between more or lesste, Departamento de Odontologia, Av. Senador Salgado Filho, 1787
ax: +55 84 3215 4138.
d.
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identified that are related to tumour progression and thus
permit the establishment of therapeutic strategies against
specific antigens.8
Matrix metalloproteinases (MMPs) are a family of zinc-
dependent endopeptidases that are able to degrade all ECM
proteins.9,10 MMPs are associated with tumour progression
and a poor prognosis due to their capacity to rupture these
physical barriers and to regulate angiogenesis and cell
proliferation.11–13 These enzymes are abundantly expressed
in various malignant neoplasms and are implicated in all
stages of tumour progression.11,14–17 Interestingly, in a
significant number of cases MMPs are expressed by stromal
cells, a finding indicating that, in addition to endogenous
production of these enzymes, tumour cells utilize proteinases
produced by stromal cells.18,19 Several studies have reported
an increased immunoexpression of MMPs in oral and head
and neck carcinomas,20,21,9 with the observation of more
intense staining at the tumour invasion front22–24 and of an
association with the development of metastases.21,25–27 The
exact determination of the MMPs involved in the processes of
tumour invasion and metastasis in different tumours would
permit the development of drugs designed to work against
specific MMPs or of inhibitors of these proteins.7,28
The objective of the present study was to evaluate the
immunohistochemical expression of MMP-1, -2, -7, -9 and -26
in SCCs of the lower lip and tongue in order to determine the
presence or absence of a correlation between the expression of
these enzymes and the anatomic location of the tumour and
histological grade of malignancy. The results are expected to
contribute to a better understanding of the biological behav-
iour of oral SCCs and of the role of MMPs in the invasiveness of
these tumours.
2. Materials and methods
Fifteen cases of tongue squamous cell carcinoma and fifteen of
lower lip squamous cell carcinoma were obtained from the
files of the Sa˜o Marcos Hospital in Teresina-PI. Patients were
surgically treated without radiotherapy or chemotherapy
prior. Samples were excluded from the study in case of
incision biopsy, specimens with inadequate material or
extensive areas of necrosis. The study was approved by the
Research Ethics Committee at UFRN.
2.1. Histopathology
Sections (5 mm) were stained with haematoxylin–eosin (HE) for
evaluation of the tumour invasion front. Next, the carcinomasTable 1 – Specifications of the antibodies used.
Antibody Clones Dilution Manufactur
Anti-MMP-1 41-1E5 1:100 Cabiochen (Onco
Anti-MMP-2 17B11 1:50 Novocastra 
Anti-MMP-7 Ab-1/ID2 1:250 Labvision/Neom
Anti-MMP-9 2C3 1:20 Novocastra 
Anti-MMP-26 AHP756 1:250 Serotec were classified according to the histological grading system
proposed by Bryne,29 which considers four parameters for the
determination of the grade of malignancy: degree of keratini-
zation, nuclear pleomorphism, invasion pattern, and inflam-
matory infiltrate. This system was adapted by the author from
his first classification system,30 which included five morpho-
logical parameters. In view of the reduction in the number of
parameters evaluated by the method of Bryne,29 a classifica-
tion of cases based on the sum of scores was adapted for this
study, with cases presenting 4–8 points being classified as low
grade and those with more than 8 points being classified as
high grade of malignancy.31
2.2. Immunohistochemical methods
For immunohistochemistry, 3-mm thick sections were
mounted on glass slides previously prepared with organosi-
lane adhesive (3-aminopropyltrithoxy-silane, Sigma Chemical
Co., USA) and submitted to the streptavidin–biotin method.
The histological sections were deparaffinized in xylene and
rehydrated in a decreasing alcohol series. The sections were
then submitted to antigen retrieval (Table 1) and blockade of
endogenous peroxidase with 10 volumes of hydrogen perox-
ide, washed in water, and incubated with Tris–HCl, pH 7.4, for
10 min. The sections were then incubated with the primary
antibodies (Table 1) diluted in 1% BSA/Tris–HCl, pH 7.4. The
reactions were developed with 0.03% diaminobenzidine as
chromogen and the slides were counterstained with Mayer’s
haematoxylin for 10 min. Finally, the sections were dehy-
drated in alcohol and cleared in xylene for mounting in
Permount resin (Fisher Scientific, USA) under a coverslip. The
positive control for MMP-1 was section of breast carcinoma
tissue, for MMP-2 was section of inflamed large bowel, for
MMP-9 was section of liver and MMP-7 and -26 were sections of
ordinary human placenta. As negative controls, samples were
treated as above, except that the primary antibody was
replaced by a solution of bovine serum albumin in PBS.
Immunostaining at the invasion front was evaluated in
triplicate by the same examiner at different times under a light
microscope. Staining for each MMP was evaluated in neoplas-
tic cells and expression was analysed semiquantitatively11
and classified as follows: negative (); low expression, less
than 10% positive cells (+); moderate expression, 10–50%
positive cells (++); intense expression, more than 50% positive
cells (+++). In addition, the expression of MMPs by stromal
cells adjacent to neoplastic cells of the invasion front was
analysed. The specimens were classified as follows according
to an adaptation of the method of Franchi et al.11: negative or
weak staining, 0–10% positive cells; expressive staining, more
than 10% positive cells.er Antigen retrieval Incubation
gene) Citrato, pH 6.0, 30 min, Steamer Overnight
EDTA, pH 8.0, 30 min, Steamer 60 min
arkers Pepsina, pH 1.8, 1%, 37 8C, 60 min Overnight
Citrato, pH 6.0, 30 min, Steamer Overnight
Pepsina, pH 1.8, 1%, 37 8C, 60 min Overnight
Fig. 1 – Immunohistochemical expression of MMPs in SCC of the tongue (400T). (a) High grade malignancy showing
moderate expression for MMP-1. (b) Low grade malignancy showing moderate expression for MMP-1. (c) High grade
malignancy showing weak expression for MMP-2. (d) Low grade malignancy showing no expression for MMP-2. (e) High
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Table 2 – Immunohistochemical reactivity for metallo-
proteinases (MMPs -1, 2, 7, 9 and 26) in the invasive front
of SCC of the tongue and lower lip. Natal/RN-2006.
MMP % of positive
cells
Low grade
(n = 17)
High
grade
(n = 15)
n % n %
MMP-1 0 2 11.76 0 0
<10% 2 11.76 2 15.38
10–50% 12 70.58 6 46.15
>50% 1 5.88 5 38.46
MMP-2 0 7 41.17 5 38.46
<10% 4 23.52 5 38.46
10–50% 6 35.29 3 23.07
>50% 0 0 0 0
MMP-7 0 2 11.76 0 0
<10% 5 29.41 0 0
10–50% 8 47.05 3 23.07
>50% 2 11.76 10 76.92
MMP-9 0 8 47.05 3 23.07
<10% 5 29.41 5 38.46
10–50% 4 23.52 4 30.76
>50% 0 0 1 7.69
MMP-26 0 0 0 0 0
<10% 5 29.41 2 15.38
10–50% 8 47.05 1 7.69
>50% 4 23.52 10 76.92
Table 3 – Immunohistochemical reactivity for metallo-
proteinases (MMPs -1, 2, 7, 9 and 26) in the stromal cells
adjacent to the invasive front of SCC of the tongue and
lower lip. Natal/RN-2006.
MMP % of positive
cells
Low grade
(n = 17)
High
grade
(n = 13)
n % n %
MMP-1 <10% 0 0 0 0
>10% 17 100 13 100
MMP-2 <10% 9 52.94 6 46.15
>10% 8 47.05 7 53.84
MMP-7 <10% 6 35.29 0 0
>10% 11 64.70 13 100
MMP-9 <10% 10 58.82 12 92.30
>10% 7 41.17 1 7.69
MMP-26 <10% 17 100 12 92.30
>10% 0 0 1 7.69
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3.1. Morphological study
Seventeen (56.67%) of the 30 cases studied exhibited a low
degree of malignancy (8 lower lip SCCs and 9 tongue SCCs),
whereas 13 (43.33%) were classified as high degree of
malignancy (7 lower lip SCCs and 6 tongue SCCs). No
significant association was observed between the anatomical
location of the tumour and histological degree of malignancy
(P > 0.05, chi-square and Fisher’s exact tests).
3.2. Immunohistochemical study
All cases investigated expressed at least two of the MMPs
studied. Some positive staining for MMP-1 in tumour cells at
the invasion front was observed in 93.33% of cases. This rate
was 60% for MMP-2, 63.33% for MMP-9, 93.33% for MMP-7, and
100% for MMP-26 (Table 2).
In general, tongue SCCs exhibited more intense MMP
staining in the parenchyma than lower lip SCCs (Figs. 1a–j and
2a–j), although this difference was statistically significant only
for MMP-9 (P < 0.05, Mann–Whitney test).
With respect to histological grade of malignancy, higher
expression of MMPs by neoplastic cells at the invasion front
was observed in high-grade tumours (Figs. 1a, c, e, g, i and 2i),
except for MMP-2 which showed the opposite tendency
(Fig. 2c and d). A significant difference in expression between
high-grade and low-grade tumours was observed for MMP-7
(P < 0.05) and MMP-26 (P < 0.05, Mann–Whitney test for
both).
Stromal expression varied widely between the MMPs
investigated. All cases studied exhibited expressive staining
for MMP-1, whereas MMP-26 was expressed in only 3.33%. No
significant difference in the expression of MMP-1, -7, -9 or -26
was observed between lower lip and tongue SCCs (Table 3).
However, the stromal expression of MMP-2 was significantly
higher in lower lip SCCs (P < 0.05).
With respect to morphological grade of malignancy, no
significant difference was observed in the stromal expression
of MMP-1, -2, -9 or -26. However, high-grade tumours exhibited
significantly more intense stromal staining for MMP-7
(P < 0.05).
After analysis of the sample as a whole, the data were
analysed statistically within each subgroup divided according
to tumour site: lower lip and tongue. For lower lip SCCs, higher
expression of MMP-1 (P < 0.05), MMP-7 (P < 0.05) and MMP-26
(P < 0.05) by neoplastic cells was observed in high-grade
tumours when compared to low-grade tumours. For tongue
SCCs, no significant differences in MMP-1, -2, -9 or -26 staining
were observed between high-grade and low-grade tumours.
Expression of MMP-7 was significantly higher in parenchyma
of high-grade tongue SCCs (P < 0.05). Immunostaining ingrade malignancy showing strong expression for MMP-7. (f) Lo
MMP-7. (g) High grade malignancy showing moderate expressi
expression for MMP-9. (i) High grade malignancy showing stron
showing strong expression for MMP-26.stromal cells did not differ significantly between high-grade
and low-grade tumours in either subgroup. There was no
significant difference in the immunohistochemical expression
of MMP-1, -2, -7, -9 or -26 between tongue carcinomas with and
without metastases.w grade malignancy showing moderate expression for
on for MMP-9. (h) Low grade malignancy showing weak
g expression for MMP-26. (j) Low grade malignancy
Fig. 2 – Immunohistochemical expression of MMPs in SCC of the lower lip (400T). (a) High grade malignancy showing
moderate expression for MMP-1. (b) Low grade malignancy showing moderate expression for MMP-1. (c) High grade
malignancy showing no expression for MMP-2. (d) Low grade malignancy showing weak expression for MMP-2. (e) High
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of SCCs and immunohistochemical expression of MMPs
showed that, in general, the higher the score of malignancy,
the higher the expression of MMPs. This correlation was
statistically significant for MMP-7 and MMP-26. MMP-7
showed a direct and significant correlation with almost all
partial scores and MMP-26 was correlated with the parameter
of tumour invasion pattern. Only the degree of keratinization
showed an inverse correlation with MMP-1 and MMP-9, but
this correlation was not significant.
4. Discussion
The biological behaviour of SCCs depends on a series of
factors, including the anatomical location of the tumour. It has
been well established in the literature that malignant tumours
located in the tongue are more aggressive, showing high rates
of recurrence and metastasis.32–35 On the other hand, lower lip
carcinomas are poorly aggressively and rarely produce
metastases.36 These factors, together with the fact that an
early diagnosis is easier to be established, seem to contribute
to the good prognosis of these carcinomas.4 On the basis of
this evidence, SCCs of the tongue and lower lip were selected
to compare tumours that commonly exhibit a distinct
biological behaviour.
Semiquantitative analysis of the expression of MMPs at the
tumour invasion front of the carcinomas studied here
demonstrated an overall higher expression of these enzymes
in cases of tongue SCCs. However, this difference was only
significant for MMP-9 (P < 0.05, Mann–Whitney test). MMP-1
showed moderate to strong expression in most cases of lip
(80%) and tongue (80%) carcinomas. On the other hand,
gelatinases were less expressed, with MMP-2 mainly showing
weak to moderate expression in both lip and tongue carcino-
mas (60%). Slightly higher expression of MMP-9 was observed
in cases of tongue SCCs, with weak to moderate expression in
67% of cases. In contrast, weak or no expression of MMP-9 was
observed in 94% of lip SCC cases.
Matrilysins showed a similar pattern of immunoexpres-
sion, with moderate to strong expression of MMP-7 and MMP-
26 in both lip (73% of cases) and tongue (80% of cases)
carcinomas.
The abundant staining for MMP-1 clearly reflects the
important role of this enzyme in the invasion of adjacent
tissues by the tumour through the destruction of ECM
components, especially collagen I. Cao et al.37 emphasized
the importance of MMP-1 for invasion and metastasis of
tongue carcinomas.
Several studies have investigated the role of MMP-2 and
MMP-9 in oral SCCs and demonstrated a relationship between
the expression of these gelatinases and tumour aggres-
siveness,20,9,38,39 a fact permitting the use of these MMPs asgrade malignancy showing moderate expression for MMP-7. (f)
MMP-7. (g) High grade malignancy showing no expression for M
for MMP-9. (i) High grade malignancy showing strong expressio
expression for MMP-26.prognostic markers or for therapeutic purposes. However,
other studies were unable to confirm these results.11,40–43 The
expression of gelatinases observed in the present study
suggests that these enzymes also play an effective role in
the development of oral SCCs, although staining was generally
less intense than that observed for MMP-1. A distinct
presentation might be observed at earlier stages of develop-
ment of these carcinomas since rupture of the basement
membrane is necessary for tumour invasion. The invasion
process is initiated by the cleavage of basement membrane
proteins that are the preferential substrates of MMP-2 and
MMP-9, such as collagen IV. Thus, immunoexpression of these
MMPs in oral SCCs may reflect the ability of these enzymes to
degrade collagen IV and gelatin.
The strong staining for matrilysins (MMP-7 and MMP-26)
observed in the oral SCC cases studied seems to indicate a high
potential of invasion and metastasis since these enzymes are
able to degrade basement membrane proteins such as laminin
and collagen IV.
The cooperation or synergism between neoplastic cells
and stromal fibroblasts in the production of MMPs has been
demonstrated in numerous experiments,11,9,41,44,45 a finding
emphasizing the fundamental role of the microenvironment
in tumour progression. The stromal area adjacent to the
invasion front was considered for the analysis of MMP
immunoreactivity in tumour stroma and only weak or
negative staining (0–10% positive cells) and expressive
staining (>10% positive cells) were evaluated. Thus, pre-
dominantly expressive staining for MMP-1 and MMP-7 was
observed in lip (100% and 87%, respectively) and tongue
carcinomas (100% and 73%). MMP-2 staining was expressive
in most cases of lip SCC (73%) and weak in tongue
carcinomas (73%). In contrast, immunoexpression of MMP-
9 and MMP-26 was weak in most cases of lip (67% and 100%,
respectively) and tongue carcinomas (80% and 93%). Statis-
tical analysis of these results only revealed significance for
MMP-2 which, curiously, was more expressed in lower lip
tumours (P < 0.05).
Taken together, the results of this study showed that
stromal cells of the oral SCC cases studied were able to
produce MMPs and that this production was more or less
efficient depending on the MMP investigated. It is believed
that these stromal enzymes potentiate the action of
MMPs produced by the parenchyma. This fact supports the
view of a marked interaction between neoplastic cells and the
adjacent stroma. This strategic interaction permits tumours
to induce stromal cells to produce proteolytic enzymes that
act in synergism with tumour enzymes and thus facilitate
the processes of invasion, migration and metastasis.
Studies in the literature have investigated the association
between an increased expression of MMPs in oral SCCs
and the primary tumour site. In this respect, Vicente et al.9
found no significant association between the immunohisto- Low grade malignancy showing moderate expression for
MP-9. (h) Low grade malignancy showing weak expression
n for MMP-26. (j) Low grade malignancy showing moderate
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tumour site.
Analysis of the expression of MMPs in parenchyma and
stroma showed an overall higher expression in tongue
carcinomas compared to lower lip carcinomas, a finding
demonstrating the higher aggressiveness of the former as
documented in the literature.35 However, this difference was
only significant for MMP-9.
Another important parameter is the association between
the expression of MMPs and the histological grade of
malignancy of carcinomas. Tunuguntla et al.46 and Fang
et al.,47 studying endometrial and colorectal carcinomas,
respectively, observed a correlation between the higher
expression of MMPs and histological grades II and III, the
presence of lymph node metastases and invasion of other
tissues, consequently contributing to a poorer prognosis. In
contrast, Pilka et al.48 and Ahokas et al.16 found expressive
staining for MMP-26 in grades I and II of endometrial and skin
carcinomas, respectively, but not in less differentiated
carcinomas classified as grade III. Vicente et al.9 demonstrated
a significant association between the histological grade of
malignancy of oral SCCs and the immunohistochemical
expression of MMP-9 but not MMP-2. In contrast, Liu et al.15
observed no significant association between MMP-2 or MMP-9
immunostaining and the degree of cell differentiation in
laryngeal carcinomas.
Considering the 30 cases evaluated in this study, higher
expression of MMPs, except for MMP-2, was observed in high-
grade tumours, with this difference being significant for MMP-
7 and MMP-26 (P < 0.05). This finding indicates a greater
proteolytic potential of tumours with a high grade of
malignancy in the cases of oral SCCs investigated. These
findings explain the greater potential of invasion and
metastasis shown by high-grade malignant tumours.49
The present study also evaluated the expression of MMP-
1, -2, -7, -9 and -26 within each subgroup (lower lip and
tongue carcinomas), analysing staining in stroma and
parenchyma of low-grade and high-grade tumours, since
the two neoplastic components are known to play a
determinant role in tumour progression. For SCCs of the
lower lip, neoplastic cells at the invasion front of high-grade
tumours expressed significantly more MMP-1, -7 and -26
than those of low-grade malignant tumours (P < 0.05).
Expressive staining for MMP-1 and absent or weak staining
for MMP-26 were observed in stromal cells adjacent to the
invasion front in all cases of tongue carcinomas. No
significant differences in stromal staining were observed,
with a predominance of expressive staining for MMP-1 and
weak staining for MMP-26.
Analysis of tumour cells at the invasion front in tongue
carcinomas showed a tendency towards increased expres-
sion of MMPs in high-grade tumours compared to low-grade
tumours. This difference was significant for MMP-7
(P < 0.05).
One important factor for the determination of the
prognosis of patients with malignant neoplasms is the
presence of metastases, which has been used as a parameter
to test the efficiency of possible markers of tumour aggres-
siveness. Hong et al.25 observed a stronger expression of
MMP-2 and MMP-9 in metastatic oral SCCs. In head and neckcarcinomas, Katayama et al.27 and Franchi et al.11 reported a
significant correlation between the expression of MMP-9 and
the occurrence of nodal or distant metastases. In contrast,
other investigators9,40,41 did not find a significant correlation
between the presence of metastases and the expression of
MMP-2 or MMP-9. In the study of Huang et al.35 on tongue
carcinomas, the expression of EMMPRIN, a glycoprotein that
stimulates the production of MMPs by stromal fibroblasts,
was not associated with nodal metastasis. Sasaki et al.,26
studying MMP-7 in lung carcinomas, and Yamamoto et al.,24
investigating MMP-26 in esophageal SCCs, reported a signifi-
cant association between metastasis and the expression of
these proteases. In the present study, although MMP
reactivity tended to be higher in the parenchyma of
metastatic carcinomas (6 cases of tongue carcinoma), no
significant difference was observed.
The correlation between morphological and immunohis-
tochemical findings observed in the present study reaffirms
and supplements one of the statements discussed earlier, i.e.,
that the expression of MMP-7 and MMP-26 is significantly
increased in high-grade oral SCCs. This may explain the higher
metastatic potential exhibited by tumours with greater
histological malignancy.
Kumagai et al.50 demonstrated that the invasion pattern of
SCCs is related to the loss of basement membrane continuity.
In agreement with these authors, the present study showed
that the more dispersed the invasion pattern of the tumours
studied, the higher the expression of MMP-26, a finding
indicating the degradation of basement membrane compo-
nents.
Analysis of the present results as a whole showed that
neoplastic cells at the invasion front of the tumours studied
were able to synthesize MMPs and to induce the production of
these enzymes by stromal cells. The high rates of positive
staining for MMPs, especially MMP-1 and matrilysins, in lower
lip and tongue carcinomas indicate the importance of these
enzymes for tumour progression.
A significant correlation between histological grade of
malignancy and expression of MMP-7 was observed for both
types of carcinomas. Since the basement membrane is
important for guidance of the process of differentiation of
membrane-bound cells, it is perfectly reasonable to believe
that degradation of this structure by MMP-7 is related to a
greater histological severity of oral SCCs.
Significant differences between groups were more fre-
quently observed for the expression of MMPs by tumour cells,
whereas in most cases stromal expression of MMPs did not
differ according to tumour site or histological grade of the
carcinomas studied.
The present results clearly demonstrate the marked
expression of MMPs in SCCs of the lip and tongue,
particularly in tumours with a high histological grade of
malignancy. Although this expression was more prominent
in parenchymatous cells, it is believed that the tumour
stroma is also a determinant factor for tumour progression.
Despite a lack of statistical significance, the small differ-
ences observed may indicate distinct stages of tumour
progression, with different events being involved in the
initial establishment of the primary tumour and in meta-
static invasion.
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